|
|
| Quarterly Results |
|
| Dr Lal Pathlabs Ltd | | Industry : Healthcare | Chairman : Arvind Lal | | Home : Indian Private | Book Value: 216.8213255 | | BSE Code : 539524 | Market Cap: 19341.4 | | NSE Code : LALPATHLAB | P / E : 52.8 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 476.00 | 531.70 | 480.10 | 431.00 | | Other Income | 15.10 | 14.10 | 15.00 | 11.60 | | Total Income | 491.10 | 545.80 | 495.10 | 442.60 | | Total Expenditure | 345.90 | 368.70 | 344.30 | 315.30 | | Operating Profit | 145.20 | 177.10 | 150.80 | 127.30 | | Interest | 6.50 | 7.10 | 7.30 | 8.40 | | Gross Profit | 138.70 | 170.00 | 143.50 | 118.90 | | Depreciation | 19.20 | 19.10 | 18.40 | 20.80 | | Tax | 31.90 | 39.80 | 35.90 | 22.10 | | Deferred Tax | -0.70 | -1.90 | -4.40 | 4.60 | | Reported Profit After Tax | 88.30 | 113.00 | 93.60 | 71.40 |
|
|
|
|
|